Bioprospecting Cryptogams as Potential Source of Unique Biodynamic Phytochemicals with Diverse Pharmaceutical Applications

  • Garima Pandey Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow – 226001, U.P., India .
  • Prateeksha . Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow – 226001, U.P., India .
  • J. Kumar Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow – 226001, U.P., India.
  • Brahma N. Singh Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow – 226001, U.P., India.
DOI https://doi.org/.

Abstract

With the advent of green pharmaceuticals, the secondary metabolites derived from plants have provided numerous leads for the
development of a wide range of therapeutic drugs; however the discovery of new drugs with novel structures has declined in the past few
years. Cryptogams including lichens, bryophytes, and pteridophytes represent a group of small terrestrial plants that remain relatively
untouched in the drug discovery process though some have been used as ethnomedicines by various tribes worldwide. Studies of their
secondary metabolites are recent but reveal unique secondary metabolites which are not synthesized by higher plants. These compounds
can have the potential to develop more potential herbal drugs for prevention and treatment of diseases The present article . deals with the
secondary metabolites and pharmacological activities of cryptogams with an objective to bring them forth as potential source of
biodynamic compounds of therapeutic value.
Keywords: Cryptogams; lichen; bryophytes; pteridophytes; secondary metabolites; pharmacology; drug discovery

Downloads

Download data is not yet available.
Statistics